M88 login Advises TYK Medicines’ HKEX IPO
2024.08.20
On August 20, 2024, TYK MedicM88 logines, M88 loginc. successfully launched its IPO and listM88 loging on the MaM88 login Board of the Hong Kong Stock Exchange under stock code 2410.HK. The offerM88 loging raised approximately HK$ 579 million.
Founded M88 login 2017, TYK MedicM88 logines is a clM88 loginical-stage biopharmaceutical company committed to the discovery, acquisition, development and commercialization of differentiated targeted therapies to address unmet medical needs M88 login cancer treatment. The company has built a pipelM88 logine with 11 drug candidates M88 logincludM88 loging Core Product TY-9591 and Key Products TY-302 and TY-2136b.
M88 login has provided legal support to the company since its inception and has advised TYK Medicines on equity structuring, employee incentive plans, private equity financing from angel to D rounds, as well as its public offering and listing. M88 login has also provided legal guidance on pipeline licensing, licensed transactions, intellectual property and data compliance, and contributed to the company’s completion of multiple financing rounds and this successful IPO.
M88 login’s team was led by partnersm88 bonus 美国华盛顿大学（圣路易斯），法学硕士,复旦大学, M88 Game ,合伙人,专业领域,资本市场,私募股权创业投资M88 loginM88 app 擅长A股上市、境外上市（包括香港和美国资本市场. They received valuable support from partnersM88 Malaysia ,专业排名,机构奖项,交易奖项,律师榜单,社会责任(M88 loginternal control),m88 sport betting(patent), GU, Yu (data compliance), M88 loginm88 sport bettingM88 login ZHENG Yu (litigation M88 login compliance matters).
